TABLE 1

Voltage-dependent block of sodium currents by tocainide, proline-like derivatives, and related benzylated analogs

The columns from left to right are as follows: drug used; concentrations able to produce the half-maximal block of sodium currents (IC50) with single 10-ms test pulses to −20 mV from a holding potential of either −140 or −70 mV. The IC50 values have been obtained during nonlinear least squares fit of the concentration-response data to the logistic equation described under Materials and Methods. Inactivated state-block refers to the affinity constants for inactivated sodium channels (Ki) calculated from the IC50 values at −140 mV (assumed as affinity for resting state, Kr) and at −70 mV (K−70) and the relative distribution of channels between resting and inactivated state at −70 mV evaluated from steady-state inactivation curves, according to the equation described under Materials and Methods. The gain of potency of the new compounds versus Toc on both resting and inactivated channels is shown as ratios between related constants values, Kr Toc/Kr drug and Ki Toc/Ki drug, respectively. The gain of potency of each compound versus inactivated state is shown as the ratio between related Kr and Ki values (Kr/Ki).

Voltage-Dependent Block Inactivated-State Block
Drug HP −140 mV IC50; KrKr Toc/Kr drug HP −70 mV IC50; K−70 Calculated KiKi Toc/Ki drugKr/Ki
μM μM μM
Toc 985 ± 49.3 1 254.0 ± 15.0 115 1 4
Benzyl-Toc 12.5 ± 0.9ab 79 1.7 ± 0.4ab 1.1 105 11
To5 329 ± 50c 3 23.3 ± 2.6c 10.9 11 30
Benzyl-To5 54.9 ± 14ab 18 7.7 ± 1.2ab 3.9 29 14
To9 240 ± 51c 4 24 ± 2.3c 10.1 11 24
Benzyl-To9 5.1 ± 1.0b 193 0.6 ± 0.1b 0.25 460 20
  • a Significant difference of benzyl analogs with respect to Benzyl-To9 (P < 0.01 and less).

  • b Significant difference of benzyl analogs with respect to related non-benzylated parent compounds (P < 0.001).

  • c Significant difference of proline-like analogs with respect to tocainide (P < 0.001).